Effects of Trimetazidine on Oxidant-Antioxidant Balance and Angiogenesis; an in Vivo Experimental Study

dc.contributor.author Kayan, Fethullah
dc.contributor.author Savas, Hasan Basri
dc.date.accessioned 2025-08-15T19:10:44Z
dc.date.available 2025-08-15T19:10:44Z
dc.date.issued 2025
dc.description.abstract Background We evaluated the effects of trimetazidine (TMZ) on the oxidative-antioxidative balance and angiogenesis in an in vivo experimental model. This study aims to evaluate the effects of trimetazidine on angiogenesis through histological analysis and to assess its impact on oxidative-antioxidative balance through biochemical measurements. Methods In this study, Ross 308 breed chicken eggs (n = 40) were used, and embryos were divided into four distinct groups. On the eighth day of incubation, the vascular density of the embryos was examined. Following the assessment of vascular development, 4-5 mL of albumin was collected via syringe to measure oxidative stress markers. Each group consisted of 10 embryos, with a total of 40 embryos used in the study. The groups were organized as follows: Control Group (CG), Bevacizumab Group (BC), Trimetazidine 10(-)(4) Group, and Trimetazidine 10(-)(5) Group. Results When the total oxidative capacity (TOC) levels were compared among the groups, the bevacizumab group exhibited significantly higher values than the control group (p < 0.05). In oxidative stress index (OSI) measurements, the bevacizumab group also showed significantly higher values compared to the control group (p < 0.05). In contrast, when the total antioxidant capacity (TAC) levels were compared, both the Trimetazidine 10(-)(4) and Trimetazidine 10(-)(5) groups demonstrated significantly higher values than the control group (p < 0.05). Regarding angiogenesis scoring, the bevacizumab group exhibited a significant anti-angiogenic effect compared to the control group. However, no statistically significant difference was observed between the Trimetazidine 10(-)(4) and Trimetazidine 10(-)(5) groups and the control group (p > 0.05). Conclusion Trimetazidine demonstrated significant antioxidant activity in an in vivo Chorioallantoic Membrane (CAM) model at both 10(-)(4) M and 10(-)(5) M concentrations. However, no positive or negative effects on angiogenesis were detected. We believe that the real-time observation of angiogenesis in our study provided significant value to our research. en_US
dc.identifier.doi 10.1186/s12872-025-04701-z
dc.identifier.issn 1471-2261
dc.identifier.scopus 2-s2.0-105003024344
dc.identifier.uri https://doi.org/10.1186/s12872-025-04701-z
dc.identifier.uri https://hdl.handle.net/20.500.12514/9149
dc.language.iso en en_US
dc.publisher BMC en_US
dc.relation.ispartof BMC Cardiovascular Disorders en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Trimetazidine en_US
dc.subject Angiogenesis en_US
dc.subject Coronary Artery Disease en_US
dc.subject Myocardial Ischemia en_US
dc.title Effects of Trimetazidine on Oxidant-Antioxidant Balance and Angiogenesis; an in Vivo Experimental Study en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 55356438400
gdc.author.scopusid 56562721800
gdc.author.wosid Kayan, Fethullah/Kfa-8591-2024
gdc.author.wosid Savas, Hasan Basri/Jts-6948-2023
gdc.description.department Artuklu University en_US
gdc.description.departmenttemp [Kayan, Fethullah] Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Cardiol, Diyarbakir, Turkiye; [Savas, Hasan Basri] Mardin Artuklu Univ, Fac Med, Dept Med Biochem, Mardin, Turkiye en_US
gdc.description.issue 1 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.volume 25 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q3
gdc.identifier.pmid 40211152
gdc.identifier.wos WOS:001465165700002
gdc.scopus.citedcount 0
gdc.wos.citedcount 0

Files